Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis

Repigmentation of hairs is a rare event that has been reported after inflammatory processes, exposure to X-irradiation and psoralen and ultraviolet A, electron beam therapy, and the intake of some drugs.1 We report on a patient with psoriasis who experienced darkening and noticeable increase in scalp hair while he was receiving anti–interleukin (IL)-17 therapy.